Can you provide the average price target for XENCOR INC stock?
20 analysts have analysed XNCR and the average price target is 28.93 USD. This implies a price increase of 148.93% is expected in the next year compared to the current price of 11.62.
NASDAQ:XNCR • US98401F1057
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XENCOR INC (XNCR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-24 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2026-02-26 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-29 | Barclays | Upgrade | Underweight -> Overweight |
| 2025-10-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2025-09-02 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-08-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-08-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-08 | Barclays | Maintains | Underweight -> Underweight |
| 2025-04-21 | William Blair | Initiate | Outperform |
| 2025-02-28 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-12 | Wells Fargo | Initiate | Overweight |
| 2024-12-02 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-11-08 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-09-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-08-06 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 174.615M 6.08% | 110.493M -36.72% | 125.576M 13.65% | 121.06M -3.60% | 126.87M 4.80% | 172.7M 36.12% | 271.33M 57.11% | 530.62M 95.56% | 780.99M 47.18% | 1.104B 41.36% | 1.538B 39.31% | |
| EBITDA YoY % growth | -120.864M -63.99% | -166.301M -37.59% | -166.99M -0.41% | -185.592M -11.14% | -136.68M 26.35% | -303.96M -122.39% | -103.081M 66.09% | -108.905M -5.65% | 4.233M 103.89% | 91.239M 2,055.42% | 317.64M 248.14% | |
| EBIT YoY % growth | -132.362M -60.44% | -178.408M -34.79% | -177.502M 0.51% | -236.343M -33.15% | -266.906M -12.93% | -272.97M -2.27% | -172.239M 36.90% | -42.207M 75.50% | 139.94M 431.56% | 369.72M 164.20% | 679.95M 83.91% | |
| Operating Margin | -75.80% | -161.47% | -141.35% | -195.23% | -210.38% | -158.06% | -63.48% | -7.95% | 17.92% | 33.49% | 44.21% | |
| EPS YoY % growth | -2.10 -125.81% | -3.51 -67.14% | -1.24 64.67% | -2.97 -139.60% | -2.85 4.13% | -2.77 2.64% | -1.96 29.47% | -0.03 98.66% | 1.38 5,378.99% | 3.21 131.74% | 5.61 74.81% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.77 -17.11% | -0.78 -90.64% | -0.78 -878.56% | -0.82 -814.71% | -0.88 -13.83% | -0.91 -16.40% | -0.88 -12.73% | -0.83 -0.33% | -0.95 -7.81% | -0.97 -6.50% | -0.95 -7.49% | -0.96 -16.08% |
| Revenue Q2Q % growth | 27.942M -14.63% | 31.051M -28.80% | 32.632M 55.40% | 33.071M 17.12% | 18.248M -34.69% | 18.94M -39.00% | 20.07M -38.50% | 20.918M -36.75% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -52.53M -29.74% | -56.61M -103.44% | -53.55M -35.28% | -56.1M -30.11% | -33.66M 35.92% | -33.66M 40.54% | -33.66M 37.14% | -33.66M 40.00% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -58.731M -36.00% | -59.178M -78.40% | -61.388M -29.19% | -62.263M -16.10% | -69.87M -18.97% | -72.42M -22.38% | -72.93M -18.80% | -75.48M -21.23% | N/A | N/A | N/A | N/A |
All data in USD
20 analysts have analysed XNCR and the average price target is 28.93 USD. This implies a price increase of 148.93% is expected in the next year compared to the current price of 11.62.
XENCOR INC (XNCR) will report earnings on 2026-05-13.
The consensus EPS estimate for the next earnings of XENCOR INC (XNCR) is -0.77 USD and the consensus revenue estimate is 27.94M USD.
The number of analysts covering XENCOR INC (XNCR) is 20.